HDFCLIFE - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.7
| Stock Code | HDFCLIFE | Market Cap | 1,32,922 Cr. | Current Price | 616 ₹ | High / Low | 821 ₹ |
| Stock P/E | 69.6 | Book Value | 82.0 ₹ | Dividend Yield | 0.34 % | ROCE | 10.3 % |
| ROE | 11.3 % | Face Value | 10.0 ₹ | DMA 50 | 624 ₹ | DMA 200 | 687 ₹ |
| Chg in FII Hold | -1.75 % | Chg in DII Hold | 2.02 % | PAT Qtr | 496 Cr. | PAT Prev Qtr | 421 Cr. |
| RSI | 52.1 | MACD | -1.25 | Volume | 48,05,338 | Avg Vol 1Wk | 40,33,404 |
| Low price | 555 ₹ | High price | 821 ₹ | PEG Ratio | 5.81 | Debt to equity | 0.18 |
| 52w Index | 22.9 % | Qtr Profit Var | 4.01 % | EPS | 8.85 ₹ | Industry PE | 72.4 |
📊 Core Financials
- Revenue Growth: Quarterly PAT rose to ₹496 Cr from ₹421 Cr, showing 4.01% growth.
- Profit Margins: ROE at 11.3% and ROCE at 10.3% indicate moderate profitability.
- Debt Ratios: Debt-to-equity of 0.18 reflects low leverage.
- Cash Flows: Dividend yield of 0.34% is modest, signaling limited cash distribution.
- Return Metrics: EPS of ₹8.85 shows steady but modest shareholder returns.
💹 Valuation Indicators
- P/E Ratio: 69.6 vs industry PE of 72.4, slightly below peers but still very high.
- P/B Ratio: Price ₹616 vs book value ₹82, trading at ~7.5x book.
- PEG Ratio: 5.81, suggesting expensive growth expectations.
- Intrinsic Value: Current price below DMA 200 (₹687) but near DMA 50 (₹624), showing weak momentum.
🏢 Business Model & Competitive Advantage
HDFC Life operates in life insurance and financial protection services. Its competitive advantage lies in strong brand recognition, diversified product portfolio, and wide distribution network. However, profitability metrics are moderate compared to valuation levels.
📈 Entry Zone & Long-Term Guidance
Entry zone looks reasonable around ₹580–₹620 given RSI (52.1) and MACD (-1.25) showing consolidation. Long-term holding is viable due to brand strength and industry growth, but valuations remain stretched.
✅ Positive
- Strong brand presence in life insurance sector.
- Low debt-to-equity ratio (0.18) ensures financial stability.
- Quarterly PAT growth of 4.01% shows steady improvement.
⚠️ Limitation
- High P/E ratio (69.6) compared to earnings power.
- Low dividend yield (0.34%) offers limited income.
📉 Company Negative News
- Stock trading below DMA 200, reflecting weak momentum.
- FII holding decreased (-1.75%), showing reduced foreign investor confidence.
📈 Company Positive News
- DII holding increased (+2.02%), signaling strong domestic institutional support.
- Quarterly PAT improved from ₹421 Cr to ₹496 Cr.
🏭 Industry
The life insurance industry in India is expanding with rising awareness and financial inclusion. Industry PE at 72.4 is high, reflecting growth expectations. Competitive pressures and regulatory oversight remain key challenges.
🔎 Conclusion
HDFCLIFE shows moderate profitability with strong brand positioning but trades at expensive valuations. Entry around ₹580–₹620 is reasonable for long-term investors seeking exposure to the insurance sector. Holding is recommended for growth potential, though returns may be capped by high valuations.
Would you like me to also compare HDFCLIFE with peers like SBI Life, ICICI Prudential Life, and Max Life to assess relative strengths?